Robb Knie - 16 Mar 2022 Form 4 Insider Report for Hoth Therapeutics, Inc. (HOTH)

Role
CEO and President, Director
Signature
/s/ Jane H. Springer as Attorney-In-Fact for Robb Knie
Issuer symbol
HOTH
Transactions as of
16 Mar 2022
Net transactions value
$0
Form type
4
Filing time
18 Mar 2022, 16:15:52 UTC
Next filing
19 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOTH Options Award $0 +500,000 $0.000000 500,000 16 Mar 2022 Common Stock 500,000 $0.5910 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant.